Stelara

Prescription drugs boost drives J&J forecasts higher, shares rise
Yahoo/Reuters
Tue, 10/15/19 - 09:52 am
JNJ
earnings
Stelara
Imbruvica
J&J gets Stelara okay in Europe for ulcerative colitis
Pharmaforum
Fri, 09/6/19 - 08:35 pm
JNJ
Stelara
Janssen
Europe
Most people pay less than $5 per month for the drug. But some pay $11,002
Stat
Wed, 04/17/19 - 09:45 am
JNJ
Janssen
Stelara
drug pricing
Stelara Shines in Three Year Crohn's Disease Study
CP Wire
Wed, 10/24/18 - 02:43 pm
Janssen
JNJ
Stelara
Crohn's Disease
clinical trials
Stelara Shines in Three Year Crohn's Disease Study
Wed, 10/24/18 - 10:05 am
Jannsen
JNJ
Stelara
Crohn's Disease
J&J's Stelara succeeds in chronic bowel disease study
Yahoo/Reuters
Tue, 10/9/18 - 11:21 am
JNJ
Stelara
ulcerative colitis
3 Drugs That Are Moving the Needle at Johnson & Johnson
Motley Fool
Thu, 04/19/18 - 09:17 am
JNJ
Darzalex
Zytiga
Stelara
earnings
Forget Remicade -- Here's How Johnson & Johnson Plans to Grow
Motley Fool
Wed, 03/14/18 - 11:34 am
JNJ
Stelara
Zytiga
Darzalex
oncology
immunology
Novartis goes 2-0 against J&J in psoriasis
Biopharma Dive
Wed, 01/17/18 - 11:36 am
Novartis
JNJ
psoriasis
Cosentyx
Stelara
J&J's Stelara shows promise against lupus in study
Yahoo/Reuters
Sun, 11/5/17 - 09:28 am
JNJ
Stelara
lupus
clinical trials
AbbVie boasts a PhIII sweep for top psoriasis contender risankizumab, but it has lots of competition
Endpoints
Thu, 10/26/17 - 09:28 am
AbbVie
psoriasis
risankizumab
Humira
Stelara
clinical trials
5 Key Drugs Critical to Johnson & Johnson's Future
Motley Fool
Sun, 10/22/17 - 09:50 am
JNJ
Stelara
Xarelto
Imbruvia
Zytiga
Darzalex
J&J psoriasis drug gets expanded U.S. approval for teens
Yahoo/Reuters
Sat, 10/14/17 - 10:58 am
JNJ
Stelara
psoriasis
FDA
10 Rock-Solid Reasons Johnson & Johnson's Near-Term Future Looks Bright
Motley Fool
Sun, 09/17/17 - 09:56 am
JNJ
Remicade
Stelara
drug pricing
Imbruvica
Xarelto
Darzalex
devices
consumer health
Johnson & Johnson shows off under-pressure Stelara's latest indication—Crohn's—in new DTC spot
Fierce Pharma
Wed, 08/2/17 - 11:30 am
JNJ
Stelara
Crohn's Disease
drug advertising
DTC ads
J&J discloses DOJ investigations into marketing, advisory practices
BioPharma Dive
Thu, 05/11/17 - 11:43 am
JNJ
DOJ
drug marketing
Remicade
Olysio
Simponi
Stelara
U.S. prosecutors zero in on J&J marketing, targeting top immunology, hep C meds
Fierce Pharma
Tue, 05/9/17 - 10:43 pm
JNJ
drug manufacturing
immunology
hepatitis C
Remicade
Simponi
Stelara
Olysio
J&J psoriasis drug Stelara tames Crohn's disease in second trial
Yahoo/Reuters
Fri, 03/18/16 - 10:41 am
JNJ
psoriasis
Stelara
Crohn's Disease
Novartis' Cosentyx proves superior to Janssen's Stelara in head-to-head comparison
BioPharma Dive
Mon, 03/7/16 - 10:00 pm
Novartis
Cosentyx
Janssen
Stelara
psoriasis
J&J's Stelara succeeds in Phase III Crohn's disease trial
Yahoo/Reuters
Mon, 10/19/15 - 09:56 am
JNJ
Stelara
Crohn's Disease
clinical trials

Pages